Sensus Healthcare Inc
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
SRTS$3.30+3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS
| (in thousands, except shares and per share data) | As of March 31, 2025 | As of December 31, 2024 |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $19,072 | $22,056 |
| Accounts receivable, net | 18,018 | 19,731 |
| Inventories | 9,923 | 10,097 |
| Prepaid inventory | 5,650 | 3,347 |
| Other current assets | 1,533 | 1,507 |
| Total current assets | 54,196 | 56,738 |
| Property and equipment, net | 2,678 | 1,997 |
| Deferred tax asset | 2,087 | 2,197 |
| Operating lease right-of-use assets, net | 633 | 581 |
| Other noncurrent assets | 616 | 652 |
| Total assets | $60,210 | $62,165 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | $5,635 | $4,811 |
| Product warranties | 294 | 329 |
| Operating lease liabilities, current portion | 246 | 204 |
| Deferred revenue, current portion | 550 | 541 |
| Total current liabilities | 6,725 | 5,885 |
| Operating lease liabilities | 408 | 398 |
| Deferred revenue, net of current portion | 43 | 55 |
| Total liabilities | 7,176 | 6,338 |
| Commitments and contingencies | ||
| Stockholders’ equity | ||
| Preferred stock, 5,000,000 shares authorized and none issued and outstanding | — | — |
| Common stock, $0.01 par value – 50,000,000 authorized; 17,036,845 issued and 16,445,036 outstanding at March 31, 2025; 17,036,845 issued and 16,495,396 outstanding at December 31, 2024 | 169 | 169 |
| Additional paid-in capital | 45,874 | 45,795 |
| Treasury stock, 591,809 and 541,449 shares at cost, at March 31, 2025 and December 31, 2024, respectively | (3,871) | (3,571) |
| Retained earnings | 10,862 | 13,434 |
| Total stockholders’ equity | 53,034 | 55,827 |
| Total liabilities and stockholders’ equity | $60,210 | $62,165 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.